AI News NQ Analysis

【Golden Biotechnology Corp.】Announcement of the Company's Board of Directors Resolution to Convene the 2026 Annual General Meeting of Shareholders (New Agenda Items Added)

NQ Score 65/100

AI Summary (NQ-processed)

Golden Biotechnology Corp. announced, following a board resolution on April 8, 2026, the addition of agenda items for its Annual General Meeting of Shareholders to be held on May 20, 2026, in Taipei. The new items include amendments to the company's articles of incorporation and the issuance of restricted stock units for employees in 2026. The meeting will also review the 2025 business report, approve financial statements, elect nine directors, and lift non-compete restrictions for new directors. Electronic voting will be available from April 20 to May 17, 2026.

AI analysis data is not yet available.

Frequently Asked Questions

Q: When will Golden Biotechnology Corp.'s Annual General Meeting of Shareholders be held?
A: It will be held on May 20, 2026.
Q: What are the main new agenda items added to this shareholders' meeting?
A: The main new agenda items are "Revision of Articles of Incorporation" and "Issuance of Restricted Stock Units for Employees in 2026."